Morgan MacBeth

416 total citations
15 papers, 273 citations indexed

About

Morgan MacBeth is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Morgan MacBeth has authored 15 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Morgan MacBeth's work include Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers) and Epigenetics and DNA Methylation (2 papers). Morgan MacBeth is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers) and Epigenetics and DNA Methylation (2 papers). Morgan MacBeth collaborates with scholars based in United States, Germany and Italy. Morgan MacBeth's co-authors include Kelly D. Sullivan, Anna L. Guarnieri, Alberto Inga, Sara Zaccara, Zdeněk Andrysík, Ahwan Pandey, Joaquı́n M. Espinosa, Matthew D. Galbraith, Robert J. Van Gulick and William A. Robinson and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Morgan MacBeth

14 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgan MacBeth United States 7 187 128 44 41 21 15 273
Bingshu Xia China 9 204 1.1× 116 0.9× 95 2.2× 60 1.5× 45 2.1× 13 347
Guilherme Francisco Brazil 10 210 1.1× 108 0.8× 94 2.1× 36 0.9× 14 0.7× 13 294
Traci Lifsted United States 4 186 1.0× 101 0.8× 84 1.9× 48 1.2× 14 0.7× 6 306
Yalei Zhang China 9 178 1.0× 158 1.2× 61 1.4× 74 1.8× 47 2.2× 14 351
Anne-Catherine Jallas France 6 196 1.0× 186 1.5× 77 1.8× 52 1.3× 31 1.5× 8 331
Oksana Zagorodna United States 5 179 1.0× 69 0.5× 60 1.4× 109 2.7× 26 1.2× 6 312
Fengting Yan United States 8 259 1.4× 86 0.7× 66 1.5× 49 1.2× 17 0.8× 18 382
Mary J. Pulvino United States 9 315 1.7× 70 0.5× 58 1.3× 55 1.3× 7 0.3× 12 376
Jingyu Xiang United States 11 178 1.0× 138 1.1× 40 0.9× 77 1.9× 17 0.8× 21 347
Ágnes Bégány Hungary 8 189 1.0× 202 1.6× 85 1.9× 36 0.9× 8 0.4× 16 304

Countries citing papers authored by Morgan MacBeth

Since Specialization
Citations

This map shows the geographic impact of Morgan MacBeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan MacBeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan MacBeth more than expected).

Fields of papers citing papers by Morgan MacBeth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan MacBeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan MacBeth. The network helps show where Morgan MacBeth may publish in the future.

Co-authorship network of co-authors of Morgan MacBeth

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan MacBeth. A scholar is included among the top collaborators of Morgan MacBeth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan MacBeth. Morgan MacBeth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Yacob, Betelehem W., John J. Arcaroli, Stacey M. Bagby, et al.. (2024). Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL). PLoS ONE. 19(4). e0298808–e0298808. 3 indexed citations
4.
Turner, Jacqueline A., Morgan MacBeth, Robert J. Van Gulick, et al.. (2023). Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity. Nature Communications. 14(1). 3214–3214. 25 indexed citations
5.
Lang, Julie, Alexis D. Leal, Sarah J. Hartman, et al.. (2022). Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models. Frontiers in Oncology. 12. 877635–877635. 9 indexed citations
6.
Abbott, Jordan K., et al.. (2022). Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles. PLoS ONE. 17(3). e0265852–e0265852. 2 indexed citations
7.
Schedel, Michaela, Sonia M. Leach, Matthew Strand, et al.. (2022). Molecular networks in atopic mothers impact the risk of infant atopy. Allergy. 78(1). 244–257. 5 indexed citations
8.
Hartman, Sarah J., Stacey M. Bagby, Betelehem W. Yacob, et al.. (2021). WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 11. 642328–642328. 18 indexed citations
9.
MacBeth, Morgan, Robert J. Van Gulick, Richard P. Tobin, et al.. (2021). Targeting the RIG-I-like receptor signaling pathway to improve the efficacy of immunotherapy in mucosal and uveal melanoma.. Journal of Clinical Oncology. 39(15_suppl). e21593–e21593. 1 indexed citations
10.
MacBeth, Morgan, Richard P. Tobin, Robert J. Van Gulick, et al.. (2021). Abstract PO048: Loss of intra-tumoral RIG-I immune signaling is a potential microbiome-mediated mechanism underlying poor anti-tumor immunity and immunotherapy resistance in mucosal melanoma. Cancer Research. 81(5_Supplement). PO048–PO048. 1 indexed citations
11.
MacBeth, Morgan, Anthony Joetham, Erwin W. Gelfand, & Michaela Schedel. (2021). Plasticity of Naturally Occurring Regulatory T Cells in Allergic Airway Disease Is Modulated by the Transcriptional Activity of Il-6. International Journal of Molecular Sciences. 22(9). 4582–4582. 6 indexed citations
12.
Mukherjee, Nabanita, Carol M. Amato, Morgan MacBeth, et al.. (2021). A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. Pharmaceuticals. 14(8). 749–749. 3 indexed citations
13.
Gulick, Robert J. Van, Carol M. Amato, Morgan MacBeth, et al.. (2020). Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas. Melanoma Research. 30(6). 562–573. 24 indexed citations
14.
Mukherjee, Nabanita, William A. Robinson, Carol M. Amato, et al.. (2020). MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells. Cell Death and Disease. 11(6). 443–443. 59 indexed citations
15.
Andrysík, Zdeněk, Matthew D. Galbraith, Anna L. Guarnieri, et al.. (2017). Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity. Genome Research. 27(10). 1645–1657. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bingshu Xia Breakdown of academic impact, for papers by Guilherme Francisco Breakdown of academic impact, for papers by Traci Lifsted Breakdown of academic impact, for papers by Yalei Zhang Breakdown of academic impact, for papers by Anne-Catherine Jallas Breakdown of academic impact, for papers by Oksana Zagorodna Breakdown of academic impact, for papers by Fengting Yan Breakdown of academic impact, for papers by Mary J. Pulvino Breakdown of academic impact, for papers by Jingyu Xiang Breakdown of academic impact, for papers by Ágnes Bégány
Rankless by CCL
2026